ATLANPOLE - Biothérapies

Thinking up tomorrow's medicine

Feeds

News

A new member: Tracers Technology, the cold chain expert

Tracers Technology

Tracers Technology is a start-up company based in Fontenay-Le-Comte (Vendée Department) which specializes in the traceability of the cold chain. It provides comprehensive solutions based on a patented innovation: the smart barcode.

IGNA, innovation in the service of genetic expertise

IGNA

IGNA, multidisciplinary laboratory of criminal expertise, celebrated its 10th anniversary last year. Stemming from Nantes University Hospital, it was created in 2003 by Professor Jean-Paul Moisan. After his accidental death in 2012, the company's reins were taken over by two of his colleagues, experts in DNA: Soizic Le Guiner and Marie-Gaëlle Le Pajolec. With a presence in Nantes (55 people) and in Marseille (6 persons), IGNA pursues a multidisciplinary path in order to follow an holistic approach and a perpetual innovation, both of which guarantee the quality of its services.

AWEL, winner of 2014 Industry “Janus” award (from the French Design Institute)

Awel International

The French Institute awards its annual “Janus” label to the most creative achievements in the fields of design. The “Janus” jury selects products and services that prioritize respect for the user and his environment. For the 2014 edition, 11 companies, including AWEL, were certified. AWEL is particularly recognized for its gravimetric diluter.

CESTI University Hospital Institute (CESTI UHI): A pilot study for a new biological cutaneous dressing for the treatment of skin loss

This research program led by Pr. Dréno (UTCG [Unit of Cell and Gene Therapy] Nantes) applies the innovative concept of cell therapy in the field of skin repair.

DHU "Oncogreffe" : funding of 4 new collaborative projects with high potential in oncology and transplant immunology

DHU Oncogreffe

Launched in the summer of 2014, the call for “DHU Oncogreffe” projects is dedicated to financing high-potential research projects on three research priorities of the University Hospital Department: innovative radionuclides immunotargeting, tumor escape, graft loss and transplant immune tolerance.

Valneva Wins Two Deloitte Technology Fast 50 Awards

Valneva

[Presse release] European biotechnology company Valneva SE announced today that it has been awarded two Deloitte In Extenso Technology Fast 50 awards and the PME Finance/ Morningstar Futur 40 award as one of France’s fastest growing technology companies.

Nantes researchers announce an important step in the fight against Duchenne Muscular Dystrophy

Atlantic Gene Therapies

The announcement was made Sunday, November 9th on “France Info” by Caroline Guiner of the Nantes Institute: Atlantic Gene Therapies. She is the first author of a study published in the Molecular Therapy journal (Nature). This work has made it possible to restore muscle strength in dogs with Duchenne muscular dystrophy, by injecting a "medicine" gene to restore dystrophin production, a protein which is essential for the proper functioning of muscles.

CARLINA Technologies signs a partnership agreement with GenBiotech

Logo Carlina Technologies

[Press release] CARLINA Technologies, a biotechnology company specialized in the development of nanomedicines, today announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein. The resultant protein will be used in bone and cartilage repair. Financial details were not disclosed. Carlina Technologies is a member of Atlanpole Biotherapies.

ONE Study: new advance for patients with transplanted organs

ONE Study, a research program of the CESTI University Hospital Institute, applies the innovative concept of cell therapy in the field of organ transplantation. A clinical trial based on this therapy and which aims at limiting the side effects of anti -rejection treatments will start in Nantes by the end of the year.

Clean Cells has just been given the status of Pharmaceutical Establishment

Clean Cells

From May 2014, Clean Cells, an “Atlanpolitan” company, has become a Pharmaceutical Facility, authorized by the French National Security Agency of Medicine and Health Products. This authorization, which concerns the quality control of pharmaceutical products, was extended on October 14th to the production of experimental drugs in biotechnology and cell therapy. This certification opens new and interesting prospects for innovative therapies and biopharmaceuticals onto the drug market.

Bio Business Week : "4 days combining concrete exercises on their research and expert coaching"

From 10 to 13 June, a dozen foreign students, selected on the basis of their motivation to put a value on their research, took part in an accelerated training in Nantes. They were led by professionals, to be enabled to create their start-up business. This multicultural group (from England, Eastern Europe, Sweden, China ...) working in the field of biotechnology, studied the themes of intellectual property, finance and funding sources, and finally produced a trial presentation.

A new member: Dentaurum Ceramics, research and ceramic manufacturing center

Dentaurum Ceramics is the ceramic research and manufacturing center of the Group Dentaurum GmbH and Co.KG, one of the European leaders in orthodontics and dentures. Established since 1994, in France near Angers, Dentaurum Ceramics develops and produces the Dentaurum group’s entire range of dental ceramics.

Cédric Le May was awarded the Daniel Steinberg prize of the best scientific publication

Crédits photo : Presse Océan - Olivier Lanrivain

Researcher at the thorax Institute, Cédric Le May was awarded the Daniel Steinberg prize of the best 2013 scientific publication.

Your news

Events

2 and 3 Dec. : BioFIT 2014

BioFit is the first European business convention entirely dedicated to Open Innovation, technology transfer and collaborative research in the field of Life Sciences. This international event brings together all professionals in the chain of innovation in the field of Life Sciences (start-up companies, academic research, private research, large companies ...) and thus promotes collaborative public / private R & D projects, and an increase in the number of licensing agreements.

10 - 11 march : 3rd Nuclear Technologies for Health Symposium

The 3rd Nuclear Technologies for Health Symposium (NTHS) will take place from 10 to 11 March 2015 in Nantes. This international meeting around radiopharmaceuticals and nuclear medicine is organized by the Labex IRON (Radiopharmaceuticals for Innovative Oncology and Neurology Laboratory of Excellence.

Our events

The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation

 

Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005). 

Atlanpole UK

Annuaire